Edgewise Therapeutics Inc Insider Transactions
Edgewise Therapeutics Inc Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 100,000 @ $21.12 | $2.11 M | 23,400 | 11/12/2025 | 11/13/2025 | |
|
Fox Jonathan C
Director |
Buy | 10,700 @ $18.64 | $199.40 K | 23,702 | 11/11/2025 | 11/13/2025 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 100,000 @ $14.60 | $1.46 M | 23,400 | 08/26/2025 | 08/28/2025 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 1,907 @ $13.39 | $25.54 K | 23,400 | 08/12/2025 | 08/14/2025 | |
|
MOORE JOHN R
General Counsel |
Sell | 2,098 @ $13.39 | $28.10 K | 10,214 | 08/12/2025 | 08/14/2025 | |
| Sell | 2,862 @ $13.39 | $38.33 K | 25,361 | 08/12/2025 | 08/14/2025 | ||
|
Derakhshan Behrad
Chief Business Officer |
Sell | 2,491 @ $13.39 | $33.36 K | 23,645 | 08/12/2025 | 08/14/2025 | |
| Sell | 1,428 @ $13.39 | $19.12 K | 86,162 | 08/12/2025 | 08/14/2025 | ||
|
KOCH KEVIN
CEO |
Sell | 7,972 @ $13.39 | $106.76 K | 30,615 | 08/12/2025 | 08/14/2025 | |
|
Derakhshan Behrad
Chief Business Officer |
Sell | 1,691 @ $16.45 | $27.82 K | 20,355 | 05/02/2025 | 05/07/2025 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 1,551 @ $16.45 | $25.52 K | 18,521 | 05/02/2025 | 05/07/2025 | |
| Sell | 1,314 @ $16.45 | $21.62 K | 81,014 | 05/02/2025 | 05/07/2025 | ||
|
MOORE JOHN R
General Counsel |
Sell | 1,930 @ $16.45 | $31.76 K | 6,531 | 05/02/2025 | 05/07/2025 | |
|
KOCH KEVIN
CEO |
Sell | 4,276 @ $16.45 | $70.36 K | 20,619 | 05/02/2025 | 05/07/2025 | |
| Sell | 5,187 @ $16.45 | $85.35 K | 21,588 | 05/02/2025 | 05/07/2025 | ||
|
Thompson Peter A.
Director, 10 percent owner: |
Buy | 124,193 @ $20.13 | $2.50 M | 443,792 | 04/03/2025 | 04/04/2025 | |
|
ORBIMED ADVISORS LLC
Director, 10 percent owner: |
Buy | 372,578 @ $20.13 | $7.50 M | 14,809,075 | 04/03/2025 | 04/04/2025 | |
|
ORBIMED ADVISORS LLC
Director, 10 percent owner: |
Buy | 124,193 @ $20.13 | $2.50 M | 443,792 | 04/03/2025 | 04/04/2025 | |
|
Thompson Peter A.
Director, 10 percent owner: |
Buy | 372,578 @ $20.13 | $7.50 M | 14,809,075 | 04/03/2025 | 04/04/2025 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 200 @ $30.02 | $6.00 K | 14,863 | 03/07/2025 | 03/11/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edgewise Therapeutics Inc FAQ's
The list of insiders at Edgewise Therapeutics Inc includes Russell Alan J, KOCH KEVIN, Thompson Peter A., ORBIMED ADVISORS LLC, MOORE JOHN R, Donovan Joanne M., Derakhshan Behrad, Carruthers R Michael, Fox Jonathan C.
Insiders have sold a total of 235.01 K Edgewise Therapeutics Inc shares in the last 12 months for a total of 4.09 M sold.
The following insiders have sold Edgewise Therapeutics Inc shares in the last 12 months: Russell Alan J ($3.63 M), KOCH KEVIN ($180.12 K), MOORE JOHN R ($59.85 K), Donovan Joanne M. ($123.68 K), Derakhshan Behrad ($61.18 K), Carruthers R Michael ($40.75 K),
Insiders have purchased a total of 1.00 M Edgewise Therapeutics Inc shares in the last 12 months for a total of 20.20 M.
The following insiders have purchased Edgewise Therapeutics Inc shares in the last 12 months: Thompson Peter A. ($10.00 M), ORBIMED ADVISORS LLC ($10.00 M), Fox Jonathan C ($199.40 K),